Japan Healthcare Venture Summit Symposium

Time/Date : October 13 (Fri), 2017 11:30-14:30 
Venue : Room F204, Annex Hall Pacifico Yokohama, Japan

Part 1 Support Efforts by Goverment Organizations Simultaneous Interpreting

11:30-11:40

Opening Remarks

Minister's Secretariat, Ministry of Health,
Labour and Welfare Assistant minister
Shigeki Shiiba

11:40-12:00

Medical venture support by Ministry of Health, Labour and Welfare

MHLW / Health Policy Bureau, Economic Affairs Division,
Venture Support Strategy Office / Director 
Yasuo Iimura

12:00-12:20

Regulatory Science Consultation on R&D Strategy
-PMDA Consultation Program-

PMDA (Pharmaceuticals and Medical Devices Agency)
Coordination Officer for Review of Breakthrough Products (Sakigake) / Coordination Officer for the Practical Application of Innovation Advancements
Masayoshi Shibatsuji

12:20-12:40

Innovative drug discovery & development supports by AMED

Director / Division of Strategic Planning and Evaluation,
Department of Innovative Drug Discovery and Development,
Japan Agency for Medical Research and Development
Toru Takashi

Part 2 Exploring Ways to Create Ecosystem of Healthcare - Focused Venture Companies Simultaneous Interpreting

13:15-13:45

Keynote Lecture
Drug discovery research in academia and expectation for pharmaceutical ventures

National Institutes of Biomedical Innovation, Health and Nutrition
Yoshihiro Yoneda

13:45-14:30

Panel Discussion

Moderator

Managing Director, Honjo International/
Chairperson of The Council for Fostering Medical Ventures
Shuji Honjo

Panelists

Director, New Ventures, Johnson &Johnson Innovation
Jun Kusunoki

President & CEO NanoCarrier 
Ichiro Nakatomi

Health2.0, Director-Japan 
Yumiko Nishimura

MHLW / Health Policy Bureau, Economic Affairs Division,
Venture Support Strategy Office / Director
Yasuo Iimura

Return
Top